Subscribe To
Evergrande isn't the only troubled chinese real estate company. another one just defaulted.
Luxury real estate developer Fantasia Holdings failed to make a $206 million bond payment on Monday....
October 5, 2021, 12:09 pm
Why camber energy shares are getting hammered today
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are falling
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are getting hammered today
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are falling
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are getting hammered today
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are falling
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are getting hammered today
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are falling
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are getting hammered today
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are falling
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are getting hammered today
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are falling
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are getting hammered today
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Why camber energy shares are falling
Camber Energy, Inc. (NYSE: CEI) shares are trading lower following a short report on the company from Kerrisdale Capital. Kerrisdale Capital noted in ...
October 5, 2021, 11:40 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...
October 5, 2021, 1:00 am